Healthcare -
Biotechnology - NASDAQ - US
$ 0.3559
0.993 %
$ 4.01 M
Market Cap
-0.01
P/E
CYCC - REVENUE
Revenue CYCC - Cyclacel Pharmaceuticals, Inc.
420 K
LAST VALUE
0.00%
2 YEAR CAGR
22.87%
5 YEAR CAGR
-9.05%
10 YEAR CAGR